# Atorvastatin to Treat Pulmonary Sarcoidosis

> **NCT00279708** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 55 (actual)

## Conditions studied

- Sarcoidosis, Pulmonary

## Interventions

- **DRUG:** Atorvastatin
- **OTHER:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT00279708
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00279708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00279708, "Atorvastatin to Treat Pulmonary Sarcoidosis". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00279708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*